Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies (Q28266067)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37829946)
(Q89479068)
(Q16195062)
(Q92007107)
(Q81240009)
(Q131844258)
(P304) 340-347
(P407) (Q1860)
(P433) 2
(P478) 46
(P577) Friday, November 27, 2009
(P921) (Q5452194)
(P1433) (Q332260)
(P1476) "Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies" (language: en)
(P2093) Shivaani Kummar
Martin E Gutierrez
Xiaohong Chen
Maria Zajac-Kaye
Min Chen
Christine A Muir
Mary Ann Yancey
Yvonne R Horneffer
Lamin Juwara
Giovanni Melillo
S Percy Ivy
Maria Merino
Barbara A Conley
James H Doroshow
Anthony J Murgo
(P2860) (Q28361532)
(Q28143497)
(Q24648565)
(Q27860904)
(Q28379145)
(Q36680209)
(Q37360814)
(Q36227796)
(Q35350578)
(Q40425901)
(Q40442466)
(Q34124337)
(Q34583912)
(Q36556311)
(Q46888363)
(Q46573472)
(Q46551678)
(Q46446464)
(Q43561101)
(Q73598986)
(Q80509552)
(Q61889855)
other details